ArticleCureus2025
A Case of Amyloid Beta-Related Angiitis: Rare Inflammatory Vasculopathy of the Central Nervous System.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral amyloid angiopathy (CAA) is associated with amyloid-beta deposition in cerebrovascular vessels, leading to spontaneous intracerebral hemorrhage (ICH). A rare manifestation, amyloid beta-related angiitis (ABRA), presents with symptoms including subacute progressive headaches, cognitive decline, and focal neurological deficits. This case report discusses a 78-year-old female patient with a history of hypertension who exhibited symptoms consistent with ABRA, including headaches and memory impairments. Diagnostic imaging revealed significant MRI findings of confluent hyperintensities and microhemorrhages, while a temporal brain biopsy confirmed granulomatous arteritis linked to amyloid angiopathy. Treatment with corticosteroids resulted in notable clinical improvement. This report underscores the importance of early diagnosis and intervention in ABRA, promoting the establishment of non-invasive diagnostic criteria to distinguish it from other CAA-related conditions, thereby potentially facilitating prompt treatment without the necessity for invasive procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.